CMV Pneumonia Diagnosis

Diagnostic Value of BAL vs. Serum Testing

The American Society of Transplantation recommends that BAL fluid testing is more sensitive than serum testing alone for diagnosing CMV pneumonia, as CMV may be present in the lungs without significant viremia 1, 2
A negative CMV PCR from BAL fluid effectively rules out CMV pneumonia due to its high negative predictive value (>99%) 1
Positive CMV PCR in BAL alone has poor specificity and requires additional confirmatory testing or clinical correlation 1

The American Journal of Transplantation suggests that signs/symptoms of pulmonary disease plus detection of CMV in lung tissue by culture, immunohistochemistry, or in situ hybridization are required for a definitive diagnosis 3, 4
The detection of CMV in both BAL and peripheral blood significantly strengthens evidence for probable CMV pneumonitis 5

In immunocompromised patients with suspected CMV pneumonia, both BAL and serum CMV testing should be performed, as recommended by the American Society of Transplantation 3, 5
Diagnostic programs for BAL should include testing for CMV and other respiratory viruses in patients with profound cellular immunosuppression 1, 2
The absence of CMV in both BAL and serum effectively rules out CMV pneumonia 1

The American College of Chest Physicians notes that CMV detection in BAL or serum may represent colonization rather than invasive disease, particularly in immunocompromised hosts 1
Prior antibiotic or antiviral therapy can influence detection rates, potentially leading to false-negative results, according to the American Thoracic Society 6